Historical record - last NADAC publication: 8/22/2018
Product Information
CEFIXIME 100 MG/5 ML SUSP is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $2.8771 per ML under NDC 68180040501. Its NADAC has been published 160 times since Oct 21, 2015.
Strength
100 mg/5mL
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180040501
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Last Updated
8/22/2018
Active Ingredients
CEFIXIMEApproval Type
Generic (ANDA)
FDA Application
ANDA065129On Market Since
4/24/2015
Pharmacological Classes
Price Statistics
The NADAC for CEFIXIME 100 MG/5 ML SUSP has been published 160 times since Oct 21, 2015, and over the history we have for it it has declined 10.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.8771 per ML |
|---|---|
| All-time high | $3.3767 (Dec 16, 2015) |
| All-time low | $2.6416 (Sep 20, 2017) |
| Median price | $3.0755 |
| Average price | $3.0572 |
| Largest weekly change | -16.1% (Sep 20, 2017) |
| Weeks tracked | 160 |
| Tracking since | Oct 21, 2015 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the CEFIXIME market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of CEFIXIME 100 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for CEFIXIME 100 MG/5 ML SUSP, manufactured by Lupin Pharmaceuticals Inc., is $2.8771 per ML (NDC 68180040501), effective Aug 14, 2019.
How has the price of CEFIXIME 100 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for CEFIXIME 100 MG/5 ML SUSP has declined 10.3%. It has been tracked across 160 weekly CMS publications since Oct 21, 2015.
What are the highest and lowest recorded NADAC prices for CEFIXIME 100 MG/5 ML SUSP?
Since Oct 21, 2015, the NADAC for CEFIXIME 100 MG/5 ML SUSP has ranged from a low of $2.6416 (Sep 20, 2017) to a high of $3.3767 (Dec 16, 2015), with a median of $3.0755 per ML.
Are there cheaper alternatives to CEFIXIME 100 MG/5 ML SUSP?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of CEFIXIME 100 MG/5 ML SUSP, so no direct lower-cost alternative is listed.
Who manufactures CEFIXIME 100 MG/5 ML SUSP?
CEFIXIME 100 MG/5 ML SUSP (NDC 68180040501) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification